Suppr超能文献

综合医疗保健系统中与严重精神疾病或物质使用障碍相关的过早死亡

Premature mortality associated with severe mental illness or substance use disorder in an integrated health care system.

作者信息

Iturralde Esti, Slama Natalie, Kline-Simon Andrea H, Young-Wolff Kelly C, Mordecai Don, Sterling Stacy A

机构信息

Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA 94612, United States of America.

Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA 94612, United States of America.

出版信息

Gen Hosp Psychiatry. 2021 Jan-Feb;68:1-6. doi: 10.1016/j.genhosppsych.2020.11.002. Epub 2020 Nov 10.

Abstract

OBJECTIVE

Research has reported shortened lifespans (by 15-30 years) for those with severe mental illness (SMI) or substance use disorder (SUD), particularly among public mental health treatment consumers. We assessed SMI- and SUD-associated mortality in the understudied setting of a large, nonprofit integrated health care system.

METHOD

This retrospective cohort study examined 2010-2017 health system and death records for 564,592 adult patients. Half had SMI/SUD diagnosis; half were a demographically matched comparison group without SMI, other mental health, or SUD diagnoses. We estimated mortality risks, adjusting for demographic and physical health factors.

RESULTS

Having SMI or SUD was associated with higher odds of death (adjusted odds ratio = 1.87) and an average 6.3 years of earlier death relative to comparison individuals. Co-occurring SMI and SUD conferred higher mortality risk from major natural and unnatural causes than did SMI with no SUD.

CONCLUSIONS

Some indicators of premature mortality were lower than those reported for U.S. public mental health consumers, but risk level varied widely by diagnosis. While patients' having insurance and broad access to care may lower risk, access to care may be insufficient to overcome the many patient-, provider-, and system-level factors contributing to poor physical health in SMI and SUD.

摘要

目的

研究报告称,患有严重精神疾病(SMI)或物质使用障碍(SUD)的人群寿命缩短(缩短15 - 30年),在公共心理健康治疗的消费者中尤为明显。我们在一个大型非营利性综合医疗保健系统这一未被充分研究的环境中,评估了与SMI和SUD相关的死亡率。

方法

这项回顾性队列研究检查了564,592名成年患者2010 - 2017年的医疗系统和死亡记录。其中一半有SMI/SUD诊断;另一半是在人口统计学上匹配的对照组,没有SMI、其他心理健康或SUD诊断。我们估计了死亡风险,并对人口统计学和身体健康因素进行了调整。

结果

患有SMI或SUD与更高的死亡几率相关(调整后的优势比 = 1.87),相对于对照组个体,平均早死6.3年。同时患有SMI和SUD的患者因主要自然和非自然原因导致的死亡风险高于仅患有SMI而无SUD的患者。

结论

一些过早死亡的指标低于美国公共心理健康消费者报告的指标,但风险水平因诊断而异。虽然患者拥有保险并能广泛获得医疗服务可能会降低风险,但获得医疗服务可能不足以克服导致SMI和SUD患者身体健康不佳的众多患者、提供者和系统层面的因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验